Applied Therapeutics (APLT) News Today $0.88 -0.14 (-13.72%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 21 at 8:55 AM | businesswire.comAPLT COURT NOTICE: BFA Law Alerts Applied Therapeutics, Inc. Investors a Securities Fraud Class Action Has Been Filed with a February 18 Court DeadlineDecember 21 at 7:59 AM | investing.comAPLT INVESTOR NOTICE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 21 at 4:30 AM | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLTDecember 20 at 4:04 PM | prnewswire.comAPLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 20 at 4:00 PM | prnewswire.comAPPLIED THERAPEUTICS BREAKING NEWS: BFA Law Announces that Applied Therapeutics, Inc. has been Sued for Securities Fraud – Investors with Losses Urged to Contact the Firm (NASDAQ:APLT)December 20 at 12:25 PM | globenewswire.comRoyal Bank of Canada Has Lowered Expectations for Applied Therapeutics (NASDAQ:APLT) Stock PriceRoyal Bank of Canada decreased their price target on shares of Applied Therapeutics from $4.00 to $1.50 and set a "sector perform" rating on the stock in a research note on Friday.December 20 at 9:24 AM | marketbeat.comApplied Therapeutics CEO Shendelman Steps DownDecember 20 at 8:56 AM | marketwatch.comApplied Therapeutics Appoints John H. Johnson as Executive ChairmanDecember 20 at 8:56 AM | markets.businessinsider.comApplied Therapeutics Faces Leadership Changes and Regulatory HurdlesDecember 20 at 7:31 AM | tipranks.comLost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyDecember 20 at 5:45 AM | prnewswire.comInvestor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc.December 19 at 11:02 PM | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. Purchasers to Secure Counsel Before Important Deadline in Securities Class Action - APLTDecember 19 at 6:58 PM | globenewswire.comClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join – Contact Levi & KorsinskyDecember 19 at 12:26 PM | globenewswire.comAPLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 19 at 6:12 AM | businesswire.comShareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLTDecember 19 at 5:45 AM | prnewswire.comAPLT ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. InvestorsDecember 19 at 12:28 AM | markets.businessinsider.comAPLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities LawsuitDecember 18 at 8:29 PM | prnewswire.comAPLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 18 at 7:26 PM | prnewswire.comAPLT Investors Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmDecember 18 at 6:52 PM | businesswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)December 18 at 6:09 PM | globenewswire.comAPLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitDecember 18 at 4:00 PM | globenewswire.comAPLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Applied Therapeutics Class Action LawsuitDecember 18 at 3:51 PM | globenewswire.comRosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their RightsDecember 18 at 12:02 PM | businesswire.comSHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Applied Therapeutics, Inc. (APLT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmDecember 18 at 11:21 AM | globenewswire.comSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Applied Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of February 18, 2025December 17, 2024 | globenewswire.comFranklin Resources Inc. Sells 3,412,035 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Franklin Resources Inc. reduced its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 33.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,800,910 shares of the cDecember 17, 2024 | marketbeat.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against Applied Therapeutics, Inc. (APLT)December 12, 2024 | investing.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of InvestorsDecember 12, 2024 | tmcnet.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of InvestorsDecember 12, 2024 | businesswire.comCharles Schwab Investment Management Inc. Acquires 457,940 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Charles Schwab Investment Management Inc. boosted its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 165.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 735,217 shaDecember 12, 2024 | marketbeat.comThe Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of InvestorsDecember 11, 2024 | businesswire.comAPPLIED THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law ViolationsDecember 7, 2024 | theglobeandmail.comWolf Popper LLP Announces Investigation on Behalf of Applied Therapeutics, Inc. InvestorsDecember 6, 2024 | globenewswire.comBuy Rating Maintained for Applied Therapeutics Amidst SORD Program Potential and Regulatory ChallengesDecember 6, 2024 | markets.businessinsider.comJanus Henderson Group PLC Grows Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Janus Henderson Group PLC lifted its stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 37.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,541,528 shares of the company's stock after pDecember 5, 2024 | marketbeat.comWill Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?December 4, 2024 | finance.yahoo.comOptimistic Outlook for Applied Therapeutics Despite FDA SetbackDecember 4, 2024 | markets.businessinsider.comLost Money on Applied Therapeutics, Inc. (APLT)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationDecember 4, 2024 | markets.businessinsider.comUBS Downgrades Applied Therapeutics (APLT)December 3, 2024 | msn.comApplied Therapeutics, Inc. (NASDAQ:APLT) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, four have assignDecember 3, 2024 | marketbeat.comApplied Therapeutics says it received FDA's warning letter for genetic disease drug studyDecember 2, 2024 | reuters.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLTDecember 2, 2024 | prnewswire.comFDA Rejects Applied Therapeutics' NDA for Govorestat, Citing Flaws; Shares Plunge 76%November 30, 2024 | finance.yahoo.comRBC Capital Downgrades Applied Therapeutics (APLT)November 30, 2024 | msn.comCitigroup Issues Pessimistic Forecast for Applied Therapeutics (NASDAQ:APLT) Stock PriceCitigroup reduced their price target on shares of Applied Therapeutics from $13.00 to $8.00 and set a "buy" rating for the company in a report on Friday.November 29, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Price Target Lowered to $5.00 at Robert W. BairdRobert W. Baird reduced their price objective on shares of Applied Therapeutics from $14.00 to $5.00 and set an "outperform" rating for the company in a report on Friday.November 29, 2024 | marketbeat.comStock Traders Purchase High Volume of Applied Therapeutics Put Options (NASDAQ:APLT)Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) saw some unusual options trading activity on Friday. Investors acquired 34,641 put options on the stock. This represents an increase of 968% compared to the typical volume of 3,244 put options.November 29, 2024 | marketbeat.comApplied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow.November 29, 2024 | barrons.comApplied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease DrugNovember 29, 2024 | investopedia.com Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Is Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! Click here now for the urgent details. APLT Media Mentions By Week APLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼0.010.60▲Average Medical News Sentiment APLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼264▲APLT Articles Average Week Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CorMedix News Mereo BioPharma Group News Xeris Biopharma News ABIVAX Société Anonyme News MeiraGTx News Cartesian Therapeutics News Monte Rosa Therapeutics News Alpha Teknova News Organogenesis News ChromaDex News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.